ANDREW PORTER: Open Payments
NPI 1720785710 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 21 payments from 13 companies in 2025. Trend: 2023 $361 · 2024 $761 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $133 |
| Travere Therapeutics, Inc. | 2 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Amgen Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Genentech USA, Inc. | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $21 |
| NxStage Medical, Inc. | 1 | $20 |
Products named: TARPEYO, JYNARQUE, TAVNEOS, Kerendia, FARXIGA, Gazyva, ULTOMIRIS, Veltassa.
Industry payments across KY — which companies pay providers there.
